|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
4486708 |
| 003 |
ICU |
| 005 |
20031020201500.0 |
| 008 |
010118s2001 njua b 001 0 eng c |
| 010 |
|
|
|a 2001016674
|
| 020 |
|
|
|a 0896038017 (alk. paper)
|
| 035 |
|
|
|a 2001016674
|
| 035 |
|
|
|a (DNLM)101085085
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a QR189.5.B33
|b M46 2001
|
| 060 |
1 |
0 |
|a WC 245
|b M5457 2001
|
| 082 |
0 |
0 |
|a 616.8/2
|2 21
|
| 245 |
0 |
0 |
|a Meningococcal vaccines :
|b methods and protocols /
|c edited by Andrew J. Pollard and Martin C.J. Maiden ; foreword by E. Richardson Moxon.
|
| 260 |
|
|
|a Totowa, N.J. :
|b Humana Press,
|c c2001.
|
| 300 |
|
|
|a xvii, 421 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Methods in molecular medicine ;
|v 66
|
| 500 |
|
|
|a Companion volume to: Meningococal disease.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t Meningococcal Vaccines and Vaccine Developments /
|r Ian M. Feavers --
|g 2.
|t Immune Response and Host-Pathogen Interactions /
|r Andrew J. Pollard and David Goldblatt --
|g 3.
|t Purification of Capsular Polysaccharide /
|r Qingling Yang and Harold Jennings --
|g 4.
|t Protein-Polysaccharide Conjugation /
|r Zhongwu Guo and Harold Jennings --
|g 5.
|t N-Propionylation /
|r Zhongwu Guo and Harold Jennings --
|g 6.
|t Outer Membrane Protein Purification /
|r Carmen Arigita, Wim Jiskoot and Matthijs R. Graaf /
|r [et al.] --
|g 7.
|t Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease /
|r Carl E. Frasch, Loek van Alphen and Johan Hoist /
|r [et al.] --
|g 8.
|t Methods for Manipulation of Transferrin-Binding Proteins /
|r Leanne M. DeWinter and Anthony B. Schryvers --
|g 9.
|t Methods for the Preparation and Crystallization of Fab Fragments in Complex with Peptide Antigens Derived from N. meningitidis Outer Membrane Proteins /
|r Richard F. Collins and Jeremy P. Derrick --
|g 10.
|t Application of Optical Biosensor Techniques to the Characterization of PorA-Antibody Binding Kinetics /
|r Janet Suker and Bambos M. Charalambous --
|g 11.
|t Construction of porA Mutants /
|r Peter van der Ley and Loek van Alphen --
|g 12.
|t Construction of LPS Mutants /
|r Peter van der Ley and Liana Steeghs --
|g 13.
|t Recombinant Proteins in Vaccine Development /
|r Myron Christodoulides, Keith A. Jolley and John E. Heckels --
|g 14.
|t Identification of Peptides that Mimic N. meningitidis LOS Epitopes Via the Use of Combinatorial Phage-Display Libraries /
|r Paul J. Brett, Ian M. Feavers and Bambos M. Charalambous --
|g 15.
|t Testing Meningococcal Vaccines for Mitogenicity and Superantigenicity /
|r Alexei A. Delvig, John H. Robinson and Lee Wetzler --
|g 16.
|t Early Experiences with Nasal Vaccines against Meningococcal Disease /
|r Johan Holst and Bjorn Haneberg --
|g 17.
|t Animal Models for Meningococcal Disease /
|r Andrew R. Gorringe, Karen M. Reddin and Pierre Voet /
|r [et al.] --
|g 18.
|t Determination of Antibody Responses to Meningococcal Antigens by ELISA /
|r Einar Rosenqvist, Helena Kayhty and Andrew J. Pollard --
|g 19.
|t Immunoblot Analysis of Sera from Patients and Vaccinees /
|r Elisabeth Wedege --
|g 20.
|t Serogroup B and C Serum Bactericidal Assays /
|r Ray Borrow and George M. Carlone --
|g 21.
|t A Modified ELISA for Measurement of High-Avidity IgG Antibodies to Meningococcal Serogroup C Polysaccharide that Correlate with Bactericidal Titers /
|r Dan M. Granoff and John J. Donnelly --
|g 22.
|t Whole-Blood Model /
|r Catherine A. Ison --
|g 23.
|t Antibody-Induced Opsonophagocytosis of Serogroup B Meningococci Measured by Flow Cytometry /
|r Terje E. Michaelsen and Audun Aase --
|g 24.
|t T-Cell Responses Against Meningococcal Antigens /
|r Lisbeth Meyer Naess, Fredrik Oftung and Audun Aase /
|r [et al.] --
|g 25.
|t CD4 T-Cell Epitope Mapping /
|r Alexei A. Delvig and John H. Robinson --
|g 26.
|t Epitope Mapping /
|r John E. Heckels and Myron Christodoulides --
|g 27.
|t Meningococcal Vaccine Trials /
|r Paddy Farrington and Elizabeth Miller --
|g 28.
|t The Introduction of Group C Conjugate Meningococcal Vaccine into the UK /
|r David M. Salisbury.
|
| 650 |
|
0 |
|a Bacterial vaccines
|v Laboratory manuals.
|
| 650 |
|
0 |
|a Neisseria meningitidis
|v Laboratory manuals.
|
| 650 |
|
0 |
|a Meningitis
|v Laboratory manuals.
|
| 650 |
1 |
2 |
|a Meningitis, Meningococcal
|x drug therapy.
|
| 650 |
1 |
2 |
|a Meningococcal Vaccines
|x therapeutic use.
|
| 650 |
|
7 |
|a Bacterial vaccines.
|2 fast
|0 http://id.worldcat.org/fast/fst00825244
|
| 650 |
|
7 |
|a Meningitis.
|2 fast
|0 http://id.worldcat.org/fast/fst01016143
|
| 650 |
|
7 |
|a Neisseria meningitidis.
|2 fast
|0 http://id.worldcat.org/fast/fst01035641
|
| 655 |
|
7 |
|a Laboratory manuals.
|2 fast
|0 http://id.worldcat.org/fast/fst01920776
|
| 700 |
1 |
|
|a Pollard, Andrew J.
|0 http://id.loc.gov/authorities/names/n96802578
|1 http://viaf.org/viaf/51873003
|
| 700 |
1 |
|
|a Maiden, Martin C. J.
|0 http://id.loc.gov/authorities/names/no2002035897
|1 http://viaf.org/viaf/39559499
|
| 730 |
0 |
|
|a Meningococcal disease.
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 035 |
|
|
|a (OCoLC)45799844
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i ad9ff2bd-6c31-551d-b4f8-fbe23aecba7e
|s 3cd6f14b-1dad-5902-9d1d-aa35f2f22036
|
| 928 |
|
|
|t Library of Congress classification
|a QR189.5.B33 M46 2001
|l JCL
|c JCL-Sci
|i 4517835
|
| 927 |
|
|
|t Library of Congress classification
|a QR189.5.B33 M46 2001
|l JCL
|c JCL-Sci
|e CRERAR
|b 57860507
|i 7086321
|
